{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:12:13Z","timestamp":1787800333999,"version":"build-2784847793"},"reference-count":120,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA055523, DA045596, DA033934, DA056299-01"],"award-info":[{"award-number":["DA055523, DA045596, DA033934, DA056299-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["P17388, 17F17388, 21K06399"],"award-info":[{"award-number":["P17388, 17F17388, 21K06399"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Human immunodeficiency virus (HIV) affects nearly 40 million people globally, with roughly 80% of all people living with HIV receiving antiretroviral therapy. Antiretroviral treatment suppresses viral load in peripheral tissues but does not effectively penetrate the blood-brain barrier. Thus, viral reservoirs persist in the central nervous system and continue to produce low levels of inflammatory factors and early viral proteins, including the transactivator of transcription (Tat). HIV Tat is known to contribute to chronic neuroinflammation and synaptodendritic damage, which is associated with the development of cognitive, motor, and\/or mood problems, collectively known as HIV-associated neurocognitive disorders (HAND). Cannabinoid anti-inflammatory effects are well documented, but therapeutic utility of cannabis remains limited due to its psychotropic effects, including alterations within brain regions encoding reward processing and motivation, such as the nucleus accumbens. Alternatively, inhibiting monoacylglycerol lipase (MAGL) has demonstrated therapeutic potential through interactions with the endocannabinoid system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present study utilized a reward-related operant behavioral task to quantify motivated behavior in female Tat transgenic mice treated with vehicle or MAGL inhibitor MJN110 (1 mg\/kg). Brain tissue was collected to assess dendritic injury and neuroinflammatory profiles, including dendritic microtubule-associated protein (MAP2ab) intensity, microglia density, microglia morphology, astrocyte density, astrocytic interleukin-1\u00df (IL-1\u00df) colocalization, and various lipid mediators.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant behavioral differences were observed; however, MJN110 protected against Tat-induced dendritic injury by significantly upregulating MAP2ab intensity in the nucleus accumbens and in the infralimbic cortex of Tat(+) mice. No or only minor effects were noted for Iba-1<jats:sup>+<\/jats:sup> microglia density and\/or microglia morphology. Further, Tat increased GFAP<jats:sup>+<\/jats:sup> astrocyte density in the infralimbic cortex and GFAP<jats:sup>+<\/jats:sup> astrocytic IL-1\u00df colocalization in the nucleus accumbens, with MJN110 significantly reducing these measures in Tat(+) subjects. Lastly, selected HETE-related inflammatory lipid mediators in the striatum were downregulated by chronic MJN110 treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings demonstrate anti-inflammatory and neuroprotective properties of MJN110 without cannabimimetic behavioral effects and suggest a promising alternative to cannabis for managing neuroinflammation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1374301","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T04:34:46Z","timestamp":1716266086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation"],"prefix":"10.3389","volume":"15","author":[{"given":"Alexis F.","family":"League","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barkha J.","family":"Yadav-Samudrala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Kolagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calista A.","family":"Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Manke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah J.","family":"Niphakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron H.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogna M.","family":"Ignatowska-Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Fitting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"B1","volume-title":"HIV and AIDS: Key facts","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00152-1","article-title":"Global, regional, and national sex-specific burden and control of the HIV epidemic 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019","volume":"8","year":"2021","journal-title":"Lancet HIV"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0383-2","article-title":"Sex differences in HIV infection","volume":"15","author":"Scully","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69152-6","article-title":"HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis","volume":"368","author":"May","year":"2006","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181b563e7","article-title":"Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States","volume":"53","author":"Harrison","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","article-title":"Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care","volume":"73","author":"Marcus","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3109\/13550280009013158","article-title":"Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues","volume":"6","author":"Hudson","year":"2000","journal-title":"J Neurovirol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40263-012-0018-x","article-title":"CSF penetration by antiretroviral drugs","volume":"27","author":"Eisfeld","year":"2013","journal-title":"CNS Drugs"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt339","article-title":"High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis","volume":"69","author":"Calcagno","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B10","article-title":"Blood-brain barrier and neuro-AIDS","volume":"19","author":"Zhang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5453.602","article-title":"HIV infection and dementia","volume":"287","author":"Gartner","year":"2000","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/35073667","article-title":"Pathways to neuronal injury and apoptosis in HIV-associated dementia","volume":"410","author":"Kaul","year":"2001","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283427da7","article-title":"Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment","volume":"25","author":"Harezlak","year":"2011","journal-title":"AIDS"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.06.003","article-title":"The potential role of HIV-1 latency in promoting neuroinflammation and HIV-1-associated neurocognitive disorder","volume":"43","author":"Sreeram","year":"2022","journal-title":"Trends Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrn2040","article-title":"HIV and antiretroviral therapy in the brain: neuronal injury and repair","volume":"8","author":"Ellis","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03785-y","article-title":"Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders","volume":"78","author":"Irollo","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09907-w","article-title":"The far-reaching HAND of cART: cART effects on astrocytes","volume":"16","author":"Gonzalez","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-021-00967-z","article-title":"Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice","volume":"27","author":"Zulu","year":"2021","journal-title":"J Neurovirol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20708","article-title":"Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice","volume":"56","author":"Bruce-Keller","year":"2008","journal-title":"Glia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/glia.20746","article-title":"HIV-1 tat and morphine have interactive effects on oligodendrocyte survival and morphology","volume":"57","author":"Hauser","year":"2009","journal-title":"Glia"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090945","article-title":"Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons","volume":"177","author":"Fitting","year":"2010","journal-title":"Am J Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/v15030590","article-title":"Depressive-like behavior is accompanied by prefrontal cortical innate immune fatigue and dendritic spine losses after HIV-1 tat and morphine exposure","volume":"15","author":"Nass","year":"2023","journal-title":"Viruses"},{"key":"B24","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1016\/j.bbih.2020.100077","article-title":"Chronic HIV-1 Tat exposure alters anterior cingulate cortico-basal ganglia-thalamocortical synaptic circuitry, associated behavioral control, and immune regulation in male mice","volume":"5","author":"Nass","year":"2020","journal-title":"Brain Behavior Immun - Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"136852","DOI":"10.1016\/j.neulet.2022.136852","article-title":"Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner","volume":"788","author":"Leibrand","year":"2022","journal-title":"Neurosci Lett"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.09.026","article-title":"Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice","volume":"73","author":"Fitting","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-013-0676-6","article-title":"Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior","volume":"220","author":"Hahn","year":"2015","journal-title":"Brain Struct Funct"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1038\/s41598-018-25109-0","article-title":"HIV-1 proteins dysregulate motivational processes and dopamine circuitry","volume":"8","author":"Bertrand","year":"2018","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00285","article-title":"Synaptic connectivity in medium spiny neurons of the nucleus accumbens: A sex-dependent mechanism underlying apathy in the HIV-1 transgenic rat","volume":"12","author":"Mclaurin","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-021-00960-6","article-title":"Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage","volume":"27","author":"Denton","year":"2021","journal-title":"J Neurovirol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-012-9369-9","article-title":"HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes","volume":"7","author":"Midde","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nbd.2017.04.015","article-title":"HIV, Tat and dopamine transmission","volume":"105","author":"Gaskill","year":"2017","journal-title":"Neurobiol Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0622-17.2017","article-title":"Selective vulnerability of striatal D2 versus D1 dopamine receptor-expressing medium spiny neurons in HIV-1 tat transgenic male mice","volume":"37","author":"Schier","year":"2017","journal-title":"J Neurosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"109239","DOI":"10.1016\/j.neuropharm.2022.109239","article-title":"SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice","volume":"220","author":"Zhu","year":"2022","journal-title":"Neuropharmacology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acs055","article-title":"Implications of apathy for everyday functioning outcomes in persons living with HIV infection","volume":"27","author":"Kamat","year":"2012","journal-title":"Arch Clin Neuropsychol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0970-1","article-title":"Depression and apathy among people living with HIV: implications for treatment of HIV associated neurocognitive disorders","volume":"19","author":"Bryant","year":"2015","journal-title":"AIDS Behav"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00735.x","article-title":"The endocannabinoid system as a target for the treatment of neurodegenerative disease","volume":"160","author":"Scotter","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/S0029665113003649","article-title":"Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications","volume":"73","author":"Pertwee","year":"2014","journal-title":"Proc Nutr Soc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/ijms23020975","article-title":"New insights and potential therapeutic targeting of CB2 cannabinoid receptors in CNS disorders","volume":"23","author":"Kibret","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.222315","article-title":"Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice","volume":"353","author":"Ignatowska-Jankowska","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X13666151102103305","article-title":"Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders","volume":"13","author":"Yui","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2011.05.009","article-title":"Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer","volume":"18","author":"Nomura","year":"2011","journal-title":"Chem Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.canlet.2011.03.007","article-title":"Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer","volume":"307","author":"Ye","year":"2011","journal-title":"Cancer Lett"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.019664","article-title":"Neuroprotective effects of MAGL (Monoacylglycerol lipase) inhibitors in experimental ischemic stroke","volume":"49","author":"Choi","year":"2018","journal-title":"Stroke"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for Alzheimer\u2019s disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.05.001","article-title":"A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer\u2019s disease","volume":"1","author":"Piro","year":"2012","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.10.023","article-title":"Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling","volume":"128","author":"Zhang","year":"2018","journal-title":"Neuropharmacology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"110031","DOI":"10.1016\/j.pnpbp.2020.110031","article-title":"Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance","volume":"104","author":"Everett","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0107-8","article-title":"Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington\u2019s disease","volume":"43","author":"Covey","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0285-21.2021","article-title":"Chronic augmentation of endocannabinoid levels persistently increases dopaminergic encoding of reward cost and motivation","volume":"41","author":"Covey","year":"2021","journal-title":"J Neurosci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat Chem Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706971","article-title":"Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro","volume":"150","author":"Vandevoorde","year":"2007","journal-title":"Br J Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1021\/cn400116z","article-title":"Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors","volume":"4","author":"Niphakis","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.229971","article-title":"The selective monoacylglycerol lipase inhibitor MJN110 produces opioid-sparing effects in a mouse neuropathic pain model","volume":"357","author":"Wilkerson","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.3390\/cells10123454","article-title":"The novel monoacylglycerol lipase inhibitor MJN110 suppresses neuroinflammation, normalizes synaptic composition and improves behavioral performance in the repetitive traumatic brain injury mouse model","volume":"10","author":"Selvaraj","year":"2021","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","first-page":"107814","DOI":"10.1016\/j.neuropharm.2019.107814","article-title":"The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors","volume":"162","author":"Feja","year":"2020","journal-title":"Neuropharmacology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.651272","article-title":"Monoacylglycerol lipase inhibitor MJN110 reduces neuronal hyperexcitability, restores dendritic arborization complexity, and regulates reward-related behavior in presence of HIV-1 tat","volume":"12","author":"League","year":"2021","journal-title":"Front Neurol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12974-020-01971-6","article-title":"Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids","volume":"17","author":"Hermes","year":"2020","journal-title":"J\u00a0Neuroinflamm"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.29399\/npa.28099","article-title":"Repeated collection of vaginal smear causes stress in mice","volume":"59","author":"Varol","year":"2022","journal-title":"Noro Psikiyatr Ars"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000497","article-title":"Behavioral battery for testing candidate analgesics in mice. II. Effects of endocannabinoid catabolic enzyme inhibitors and \u03949-tetrahydrocannabinol","volume":"377","author":"Diester","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"B66","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2006.01.016","article-title":"Enhanced sucrose and Polycose preference in sweet \u201csensitive\u201d (C57BL\/6J) and \u201csubsensitive\u201d (129P3\/J) mice after experience with these saccharides","volume":"87","author":"Sclafani","year":"2006","journal-title":"Physiol Behav"},{"key":"B68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molmet.2019.05.010","article-title":"Impact of dietary sucrose on adiposity and glucose homeostasis in C57BL\/6J mice depends on mode of ingestion: liquid or solid","volume":"27","author":"Togo","year":"2019","journal-title":"Mol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3094-12.2013","article-title":"Adenosine transporter ENT1 regulates the acquisition of goal-directed behavior and ethanol drinking through A2A receptor in the dorsomedial striatum","volume":"33","author":"Nam","year":"2013","journal-title":"J Neurosci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0936-17.2017","article-title":"Abnormal microglia and enhanced inflammation-related gene transcription in mice with conditional deletion of ctcf in camk2a-cre-expressing neurons","volume":"38","author":"Mcgill","year":"2018","journal-title":"J Neurosci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"57648","DOI":"10.3791\/57648-v","article-title":"Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using imageJ","volume":"5","author":"Young","year":"2018","journal-title":"J Vis Exp"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J Microsc"},{"key":"B74","doi-asserted-by":"publisher","first-page":"106483","DOI":"10.1016\/j.prostaglandins.2020.106483","article-title":"Improved quantification of lipid mediators in plasma and tissues by liquid chromatography tandem mass spectrometry demonstrates mouse strain specific differences","volume":"151","author":"Armstrong","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B75","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0278-5846(00)00119-6","article-title":"Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain","volume":"24","author":"Melis","year":"2000","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(01)00210-X","article-title":"Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system","volume":"104","author":"Braida","year":"2001","journal-title":"Neuroscience"},{"key":"B77","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.phrs.2007.09.005","article-title":"Endocannabinoid system involvement in brain reward processes related to drug abuse","volume":"56","author":"Solinas","year":"2007","journal-title":"Pharmacol Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.12.015","article-title":"The effects of acutely administered 3,4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level-dependent resting state functional connectivity","volume":"78","author":"Carhart-Harris","year":"2015","journal-title":"Biol Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.05.027","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms","volume":"75","author":"Bloomfield","year":"2014","journal-title":"Biol Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2011.00356.x","article-title":"Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study","volume":"17","author":"Leroy","year":"2012","journal-title":"Addict Biol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/mp.2016.21","article-title":"Deficits in striatal dopamine release in cannabis dependence","volume":"22","author":"Van De Giessen","year":"2017","journal-title":"Mol Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1949","article-title":"Variability, compensation and homeostasis in neuron and network function","volume":"7","author":"Marder","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1312-13.2013","article-title":"Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture","volume":"33","author":"Hargus","year":"2013","journal-title":"J Neurosci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10844","article-title":"HIV-1 Tat inhibits long-term potentiation and attenuates spatial learning [corrected]","volume":"55","author":"Li","year":"2004","journal-title":"Ann Neurol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145928","article-title":"Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells","volume":"6","author":"Van Der Heijden","year":"2021","journal-title":"JCI Insight"},{"key":"B86","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1440-1819.2008.01841.x","article-title":"Neuropsychological impairment and gender differences in HIV-1 infection","volume":"62","author":"Failde-Garrido","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/cells11050857","article-title":"Inhibitory neurotransmission is sex-dependently affected by tat expression in transgenic mice and suppressed by the fatty acid amide hydrolase enzyme inhibitor PF3845 via cannabinoid type-1 receptor mechanisms","volume":"11","author":"Xu","year":"2022","journal-title":"Cells"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.04.029","article-title":"Sex-specific neurogenic deficits and neurocognitive disorders in middle-aged HIV-1 Tg26 transgenic mice","volume":"80","author":"Putatunda","year":"2019","journal-title":"Brain Behav Immun"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.551921","article-title":"Sex differences in the patterns and predictors of cognitive function in HIV","volume":"11","author":"Rubin","year":"2020","journal-title":"Front Neurol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"114226","DOI":"10.1016\/j.expneurol.2022.114226","article-title":"Persistent sensory changes and sex differences in transgenic mice conditionally expressing HIV-1 Tat regulatory protein","volume":"358","author":"Toma","year":"2022","journal-title":"Exp Neurol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1618","article-title":"Conditional expression of HIV-1 Tat in the mouse alters the onset and progression of tonic, inflammatory, and neuropathic hypersensitivity in a sex-dependent manner","volume":"24","author":"Bagdas","year":"2020","journal-title":"Eur J Pain"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001764","article-title":"Differences in cognitive function between women and men with HIV","volume":"79","author":"Maki","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002012","article-title":"Sex differences in HIV-associated cognitive impairment","volume":"32","author":"Sundermann","year":"2018","journal-title":"AIDS"},{"key":"B94","doi-asserted-by":"publisher","first-page":"104583","DOI":"10.1016\/j.yhbeh.2019.104583","article-title":"Effects of the estrous cycle and ovarian hormones on cue-triggered motivation and intrinsic excitability of medium spiny neurons in the Nucleus Accumbens core of female rats","volume":"116","author":"Alonso-Caraballo","year":"2019","journal-title":"Horm Behav"},{"key":"B95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.physbeh.2017.06.009","article-title":"Food restriction-induced changes in motivation differ with stages of the estrous cycle and are closely linked to RFamide-related peptide-3 but not kisspeptin in Syrian hamsters","volume":"190","author":"Benton","year":"2018","journal-title":"Physiol Behav"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2005.08.001","article-title":"Taste responses to dilute sucrose solutions are modulated by stage of the estrous cycle and fenfluramine treatment in female rats","volume":"86","author":"Atchley","year":"2005","journal-title":"Physiol Behav"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1159\/000122531","article-title":"Modifications of the striatal dopamine metabolism during the estrus cycle in mice","volume":"21","author":"Jori","year":"1976","journal-title":"Neuroendocrinology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2006.01657.x","article-title":"Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia","volume":"36","author":"Brabers","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"B99","doi-asserted-by":"publisher","first-page":"861231","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2012.00328","article-title":"Premature and accelerated aging: HIV or HAART","volume":"3","author":"Smith","year":"2012","journal-title":"Front Genet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.bbih.2021.100235","article-title":"The role of oxidative stress in HIV-associated neurocognitive disorders","volume":"13","author":"Buckley","year":"2021","journal-title":"Brain Behav Immun Health"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134437","article-title":"Monoacylglycerol lipase regulates fever response","volume":"10","author":"Sanchez-Alavez","year":"2015","journal-title":"PloS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"Fitzgerald","year":"2004","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"132ra154","DOI":"10.1126\/scitranslmed.3003787","article-title":"Vascular COX-2 modulates blood pressure and thrombosis in mice","volume":"4","author":"Yu","year":"2012","journal-title":"Sci Transl Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"103007","DOI":"10.1016\/j.bioorg.2019.103007","article-title":"Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies, (2008-2019)","volume":"89","author":"Sharma","year":"2019","journal-title":"Bioorg Chem"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem Rev"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.02.034","article-title":"Inhibition of 5-lipoxygenase is associated with downregulation of the leukotriene B4 receptor 1\/Interleukin-12p35 pathway and ameliorates sepsis-induced myocardial injury","volume":"166","author":"Xie","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1021\/jacsau.1c00177","article-title":"Biosynthetic crossover of 5-lipoxygenase and cyclooxygenase-2 yields 5-hydroxy-PGE(2) and 5-hydroxy-PGD(2)","volume":"1","author":"Nakashima","year":"2021","journal-title":"JACS Au"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001719","article-title":"Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients","volume":"128","author":"Holloway","year":"2013","journal-title":"Circulation"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30036-9","article-title":"HIV and cardiovascular disease","volume":"7","author":"So-Armah","year":"2020","journal-title":"Lancet HIV"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-4690-9-4","article-title":"Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system","volume":"9","author":"Bertin","year":"2012","journal-title":"Retrovirology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2013.10.012","article-title":"Astrocyte loss and astrogliosis in neuroinflammatory disorders","volume":"565","author":"Hostenbach","year":"2014","journal-title":"Neurosci Lett"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J\u00a0Neurosci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2186::AID-ANA8>3.3.CO;2-V","article-title":"Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine","volume":"47","author":"Nath","year":"2000","journal-title":"Ann Neurol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-019-00015-z","article-title":"The neuroprotective effect of doxycycline on neurodegenerative diseases","volume":"35","author":"Santa-Cecilia","year":"2019","journal-title":"Neurotox Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12421","article-title":"Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis","volume":"18","author":"Teeraananchai","year":"2017","journal-title":"HIV Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab Rev"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200203080-00005","article-title":"The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir","volume":"16","author":"Kosel","year":"2002","journal-title":"AIDS"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-4-200308190-00008","article-title":"Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial","volume":"139","author":"Abrams","year":"2003","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1374301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T04:34:52Z","timestamp":1716266092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1374301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":120,"alternative-id":["10.3389\/fimmu.2024.1374301"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1374301","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"article-number":"1374301"}}